Pharmaceuticals · Pharmaceuticals: Other · NSE: SATKARTAR · data 2026-10-30

Sat Kartar Life Limited

₹130-3.09% on 30 OctHealth: Strong 7.7/10

Feb 2026Low ₹116.05 · High ₹205-11.9%

In plain words

Price: 40.9% below its 52-week high of ₹219.8.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹130

Market cap

₹212 cr

P/E

10.7

P/B

2.4

ROE

28.7%

ROCE

34.8%

Debt / equity

0.04

Dividend yield

0.52%

1-year return

-28.2%

52-week high

₹219.8

52-week low

₹110.3

Operating margin

11.1%

Growth

Revenue (last 12 months)	₹225 cr
Net profit (last 12 months)	₹19 cr
Sales growth, 3 years (yearly)	34.2%
Profit growth, 3 years (yearly)	89.7%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Sat Kartar Life Limited debt-free?

Its latest reported debt-to-equity ratio is 0.04, which is very low.

What is Sat Kartar Life Limited's P/E ratio?

About 10.7, based on the last 12 months' earnings and a price of ₹130 (data 2026-10-30).

What is the 52-week high and low of Sat Kartar Life Limited?

The 52-week high is ₹219.8 and the 52-week low is ₹110.3.

Similar companies

Amrutanjan Health Care Limited (AMRUTANJAN) · Shri Ahimsa Naturals Limited (SHRIAHIMSA) · Influx Healthtech Limited (INFLUX) · Lyka Labs Limited (LYKALABS) · Natural Capsules Limited (NATCAPSUQ)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SATKARTAR in NSE Scanner →